Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.027 USD | -3.57% | +20.43% | +31.46% |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
Sales 2020 | - | Sales 2021 | - | Capitalization | 29.41M 2.34B |
---|---|---|---|---|---|
Net income 2020 | -4M -318M | Net income 2021 | -5M -398M | EV / Sales 2020 | - |
Net Debt 2020 | 399K 31.78M | Net cash position 2021 | 670K 53.36M | EV / Sales 2021 | - |
P/E ratio 2020 |
-2.11
x | P/E ratio 2021 |
-1.44
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 99.95% |
1 week | +20.43% | ||
1 month | -6.35% | ||
3 months | +2.19% | ||
6 months | +154.55% | ||
Current year | +31.46% |
Managers | Title | Age | Since |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 10/02/21 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 11/05/22 |
Theresa Heah
BRD | Director/Board Member | 46 | 03-30 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 0.027 | -3.57% | 75 915 |
26/04/24 | 0.028 | +11.11% | 5,000 |
25/04/24 | 0.0252 | -9.68% | 76,000 |
24/04/24 | 0.0279 | +9.63% | 10,700 |
23/04/24 | 0.0254 | +4.30% | 197,414 |
Delayed Quote OTC Markets, April 29, 2024 at 08:19 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+47.70% | 41.61B | |
+12.31% | 41.34B | |
-8.83% | 26.59B | |
+6.79% | 25.49B | |
-23.12% | 18.12B | |
+30.04% | 12.24B | |
-2.24% | 11.76B | |
+8.42% | 11B |
- Stock Market
- Equities
- CUBT Stock
- CUBT Stock